Showing results (211-220 of 259) with videos related to

Sort By:
Pageof 26
Radiology|November 30, 1999
Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphomaL J King, S N Hasnain, J A Webb, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 31, 2014
A randomized, open-label, dose-response study of losartan in hypertensive childrenNicholas J A Webb, Thomas G Wells, Shahnaz Shahinfar, et al.
Pediatric Nephrology (Berlin, Germany)|August 20, 2002
Serum leptin and IGF-I during growth hormone treatment in chronic renal failureLeena Patel, Nicholas J A Webb, Mark G Bradbury, et al.
Sports Medicine - Open|August 28, 2020
United States Under-19 Rugby-7s: Incidence and Nature of Match Injuries During a 5-year Epidemiological StudyVictor Lopez, Richard Ma, Meryle G Weinstein, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|February 1, 2003
Steroid-sensitive nephrotic syndrome and vascular endothelial growth factor gene polymorphismsR C L Holt, S A Ralph, N J A Webb, et al.
European Neurology|December 5, 2002
Foramen ovale recordings: a presurgical investigation in epilepsyU C Wieshmann, C E Denby, P R Eldridge, et al.
Pharmaceutics|June 28, 2023
Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over StudyJuliane Münch, Isabelle Sessler, Hans Martin Bosse, et al.
Pediatric Nephrology (Berlin, Germany)|April 14, 2018
Patterns and frequency of renal abnormalities in Fanconi anaemia: implications for long-term managementVijaya Sathyanarayana, Beth Lee, Neville B Wright, et al.
Clinical Transplantation|August 23, 2019
Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate- or prolonged-release tacrolimusKarel Vondrak, Francesco Parisi, Anil Dhawan, et al.
Pediatric Nephrology (Berlin, Germany)|March 24, 2017
Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney diseaseNicholas J A Webb, Gary Lerner, Bradley A Warady, et al.
Pageof 26